Using nanoparticles, Yale researchers have developed a drug-delivery system that could reduce organ transplant complications by hiding the donated tissue from the recipient’s immune system.
About 25,000 organ transplants are performed in the U.S. each year. Despite significant advances in the field, short-term and long-term organ rejection still poses a risk (rejection rates vary depending on the type of organ). The risk of rejection is even higher when the donor is deceased, due to organ damage.
T cells, the white blood cells that identify and attack foreign bodies, are one of the main culprits behind organ rejection. The most potent of these, known as effector memory T cells, are activated by a group of proteins known as human leukocyte antigens (HLAs) on the surface of endothelial cells lining the donated organ’s blood vessels. Researchers can silence the proteins with small interfering RNA (siRNA), a double-stranded RNA that hinders the expression of targeted genes. When delivered conventionally, however, the effects of siRNA last only a few days. A transplanted organ from a deceased donor typically needs weeks to “heal” and reduce the risk of rejection. The siRNA can also cause side effects in endothelial cells of other organs, which don’t need treatment, when administered to the whole body.
To give the siRNA more staying power, the researchers developed a drug delivery system in which polymer-based nanoparticles carry siRNA to the site of the graft and slowly release the drug. They also developed methods for introducing the nanoparticles into the donor organ before it is transplanted, so that only the organ is treated, not the whole body. The results of their work are published in the journal Nature Communications.
The particles — made in the Yale lab of Mark Saltzman, the Goizueta Foundation Professor of Chemical and Biomedical Engineering — can be tuned for specific properties. Saltzman, who is also a member of the Yale Cancer Center, said these nanoparticles were designed to have a slight positive charge to interact with the negative charge of the siRNA’s nucleic acid. This affinity between the two materials makes the particle a natural carrier for the drug, unlike commercially available nanoparticles that can hold only a limited amount of the drug.
For the study, the researchers treated part of a human artery — a few millimeters in diameter — with the siRNA-loaded nanoparticles and transplanted it into the abdominal aorta of an immune-deficient mouse inoculated with human T cells. The researchers found that the nanoparticles were still present in the donated tissue and significantly silenced the proteins’ expression up to six weeks after transplantation. Additionally, there was no damage to the endothelial cells of untargeted organs.
The first few weeks after the transplant are critical, especially when the organ donor is deceased, said Jordan Pober, the Bayer Professor of Translational Medicine and professor of immunobiology, pathology, and dermatology at Yale.
“If we delay the start of the rejection response, it should be milder and more easily controlled and lead to less late rejection,” said Pober, who is a co-author of the study and also director of Yale’s Human and Translational Immunology program.
Focusing on kidney transplants (by far the most common type of organ transplant performed), Saltzman and Pober are looking to apply the delivery system to a process known as ex vivo normothermic machine perfusion. Developed for kidneys by colleagues at Cambridge University, the process involves pumping warm, oxygenated red blood cells through an organ removed from a deceased donor to repair any damage to the organ before implanting it in the recipient. The Yale researchers plan to add the nanoparticles to the red blood cells to provide controlled delivery of the siRNA to the kidney’s endothelial cells.
Learn more: Nanoparticles trick body into accepting organ transplants
The Latest on: Nanoparticle-based drug-delivery system
[google_news title=”” keyword=”nanoparticle-based drug-delivery system” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Diamond dust shines bright: A safer contrast agent for MRI scanson April 27, 2024 at 1:54 am
In a magnetic resonance imaging experiment, nanoscale diamond particles meant for a totally different purpose shined brightly—considerably brighter than the genuine contrast agent, the heavy metal ...
- Scientists learn from caterpillars how to create self-assembling capsules for drug deliveryon April 26, 2024 at 8:00 am
Self-assembling molecules that spontaneously organize themselves to form complex structures are common in nature. For example, the tough outer layer of insects, called the cuticle, is rich in proteins ...
- Learning from caterpillars to create self-assembling capsules for drug deliveryon April 25, 2024 at 5:00 pm
The researchers are applying for a patent for their innovation, based on their study findings that were ... paving the way for a customisable drug delivery system,” said Assoc Prof Yu. “Our peptide ...
- ISS National Lab-Sponsored Research Could Produce Nanomaterials for Life-Saving Therapies and Precision Drug Deliveryon April 25, 2024 at 11:34 am
Arthritis is a crippling disease, affecting approximately one in four adults. It wreaks havoc on our joints by breaking down cartilage, the cushioning between bones. Once that cartilage deteriorates, ...
- A nanophotonic fiber-tip solution to detect the ultrasmallon April 24, 2024 at 5:00 pm
And in drug development, a host of nanoparticles are used to make the drug delivery systems of the future ... “There are sensors based on fiber-optic technologies that can measure liquids and gases ...
- A closed-loop drug-delivery system could improve chemotherapyon April 24, 2024 at 2:02 pm
When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient's body surface area. This is estimated by plugging the patient's height and weight into an equation ...
- Ultrasensitive photonic crystal detects single particles down to 50 nanometerson April 24, 2024 at 12:49 pm
Using an ultrasensitive photonic crystal, TU/e researchers were able to detect single particles down to 50 nanometers in diameter. The new research has just been published in the journal Optica.
- Cows' milk particles used for effective oral delivery of drugson April 24, 2024 at 11:16 am
Researchers have found that tiny particles present in cows' milk could offer, for the first time, an effective method for the oral delivery of RNA drugs.
- Engineering Powerful Vaccines with Lipid Nanotechnologyon April 21, 2024 at 6:15 am
In this, lipid nanoparticle (LNP) technology has emerged as highly promising. Progress in medical science has facilitated the seamless integration of lipid nanotechnology into standard therapy, ...
- Drug delivery innovations push forth women’s healthon April 11, 2024 at 3:09 am
From nanoparticles to transdermal patches, Pharmaceutical Technology takes a look at the latest in drug delivery technologies for women's health.
via Google News and Bing News